COVID-19 and the Liver
AASLD created an expert panel to provide clinically useful information for hepatologists, liver transplant care providers, and their patients. The following resources are designed to provide clinicians with clinical guidance and resources to share with patients.
COVID-19 and the Liver Webinar Series
In response to the COVID-19 pandemic, AASLD has created a series of webinars dedicated to ongoing discoveries and discussions about how it affects the care of liver patients. These webinars, including those in which we collaborated with sister organizations, are located on the "COVID-19 and the Liver Webinar Series" page.
Statement on COVID-19 Vaccines and Clinical Best Practice for Hepatology and Liver Transplant Providers
This document provides guidance for hepatology and liver transplant providers for managing patients with liver disease and liver transplant recipients in the wake of the COVID-19 pandemic. Our aim is to provide a template for developing clinical recommendations and policies to mitigate the impact of the COVID-19 pandemic on liver patients and health care providers.
This 12-page document updates and replaces 2 larger documents, "Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement" and "AASLD expert panel consensus statement: Vaccines to prevent COVID-19 in patients with liver disease".
Download the expert panel consensus statement:
Joint Society Messages
Joint Society Message: Supplemental Funding for VA Research to Support COVID-19 Research Efforts Needed
Joint Society Message: Use of Personal Protective Equipment in GI Endoscopy
Joint Society Message: Gastroenterology Professional Society Guidance on Endoscopic Procedures during the COVID-19 Pandemic
Joint GI Society Message: COVID-19 Clinical Insights for Our Community of Gastroenterologists and Gastroenterology Care Providers
Additional Resources for Clinicians
Resources for Trainees and Early Career Health Care Professionals
AASLD hosted a "Trainee and Early Career Experience in Hepatology during COVID-19" webinar. Download the Q&A document [PDF].
What You Can Do
- Submit COVID-19 Manuscripts. AASLD is seeking COVID-19 manuscript submissions. Read the letter from AASLD former journal Editors-in-Chief David Cohen, Paul Martin and Gyongyi Szab for details.
Submit to Our Journals
- Join the Conversation about COVID-19. AASLD members have an outlet to share and discuss COVID-19 and how it's affecting care delivery to patients with liver disease.
See the Latest Posts
- Report Cases to the SECURE-Liver Registry. UNC-Chapel Hill aims to assess outcomes of COVID-19 in patients with chronic liver disease and prior liver transplant including updated questions on the role of living conditions and employment, alcohol use, thromboembolic complications, novel COVID-19 therapies, emerging SARS-CoV-2 variants and post-vaccination infections. To help further their research, report cases (hyperlinked text for “report cases”) of COVID-19 in chronic liver disease and post-liver transplant patients, regardless of severity of COVID-19 (including asymptomatic patients detected through public health screening).
Submit a Case